Free Trial

HealthEquity, Inc. (NASDAQ:HQY) Shares Sold by Physician Wealth Advisors Inc.

HealthEquity logo with Medical background
Remove Ads

Physician Wealth Advisors Inc. reduced its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 21.1% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 53,549 shares of the company's stock after selling 14,296 shares during the quarter. HealthEquity makes up 0.9% of Physician Wealth Advisors Inc.'s investment portfolio, making the stock its 28th biggest holding. Physician Wealth Advisors Inc. owned about 0.06% of HealthEquity worth $5,138,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. CIBC Private Wealth Group LLC boosted its position in shares of HealthEquity by 0.4% in the 4th quarter. CIBC Private Wealth Group LLC now owns 63,853 shares of the company's stock valued at $6,369,000 after purchasing an additional 231 shares during the period. California Public Employees Retirement System increased its holdings in shares of HealthEquity by 9.9% in the 4th quarter. California Public Employees Retirement System now owns 365,778 shares of the company's stock valued at $35,096,000 after acquiring an additional 32,807 shares during the period. Level Four Advisory Services LLC raised its position in HealthEquity by 5.3% in the 4th quarter. Level Four Advisory Services LLC now owns 2,736 shares of the company's stock valued at $263,000 after purchasing an additional 138 shares during the last quarter. Premier Fund Managers Ltd boosted its stake in HealthEquity by 22.7% during the 4th quarter. Premier Fund Managers Ltd now owns 11,076 shares of the company's stock worth $1,073,000 after purchasing an additional 2,046 shares during the period. Finally, Pictet Asset Management Holding SA grew its position in HealthEquity by 14.6% during the 4th quarter. Pictet Asset Management Holding SA now owns 13,833 shares of the company's stock worth $1,327,000 after purchasing an additional 1,765 shares during the last quarter. Hedge funds and other institutional investors own 99.55% of the company's stock.

Remove Ads

HealthEquity Price Performance

HealthEquity stock traded down $4.05 during trading hours on Thursday, hitting $84.69. The stock had a trading volume of 510,877 shares, compared to its average volume of 733,396. HealthEquity, Inc. has a 1-year low of $65.01 and a 1-year high of $115.59. The stock has a market capitalization of $7.33 billion, a price-to-earnings ratio of 77.70, a PEG ratio of 1.60 and a beta of 0.62. The stock's fifty day moving average is $102.66 and its two-hundred day moving average is $96.30. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20.

Wall Street Analysts Forecast Growth

HQY has been the subject of several recent research reports. Wells Fargo & Company increased their target price on shares of HealthEquity from $110.00 to $125.00 and gave the stock an "overweight" rating in a research note on Wednesday, February 26th. Royal Bank of Canada increased their price objective on HealthEquity from $100.00 to $105.00 and gave the stock an "outperform" rating in a research report on Tuesday, December 10th. Raymond James raised HealthEquity from an "outperform" rating to a "strong-buy" rating and dropped their target price for the company from $120.00 to $115.00 in a report on Tuesday, March 25th. Barrington Research reaffirmed an "outperform" rating and set a $112.00 price target on shares of HealthEquity in a report on Friday, March 14th. Finally, JMP Securities lifted their price objective on shares of HealthEquity from $105.00 to $107.00 and gave the company a "market outperform" rating in a research report on Tuesday, December 10th. One equities research analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, HealthEquity presently has a consensus rating of "Buy" and an average target price of $112.58.

Read Our Latest Analysis on HealthEquity

Insider Activity at HealthEquity

In related news, Director Robert W. Selander sold 5,750 shares of the stock in a transaction on Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the sale, the director now owns 78,219 shares of the company's stock, valued at $8,704,992.51. This trade represents a 6.85 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 2.20% of the stock is owned by corporate insiders.

About HealthEquity

(Free Report)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Featured Stories

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

Should You Invest $1,000 in HealthEquity Right Now?

Before you consider HealthEquity, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthEquity wasn't on the list.

While HealthEquity currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

3 Stocks to Buy on the Dip—and 3 to Dump Fast
Trump Tariffs Tumble the Stock Market—Here’s How to Protect Your Money
Donald Trump Owns These 7 Stocks, Should You?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads